Towards a molecular characterisation of pathological pathways.
about
Network neighbors of drug targets contribute to drug side-effect similarityDockAnalyse: an application for the analysis of protein-protein interactions.Integrated analysis identifies interaction patterns between small molecules and pathwaysInterspecies translation of disease networks increases robustness and predictive accuracy.A novel framework for the comparative analysis of biological networks.Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic dietProof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations.Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?Platelet aggregation pathway network-based approach for evaluating compounds efficacy.A network medicine approach to human disease.Microarray analysis of genes and gene functions in disc degeneration.Systems biology and modeling in neuroblastoma: practicalities and perspectives.How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology.From protein interaction networks to novel therapeutic strategies.Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine.DrugBank and its relevance to pharmacogenomics.Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
P2860
Q28479003-A0E61D50-F52F-4549-934F-90500B54E335Q33726193-715697E4-3429-4434-83DE-4521FCFCFAEBQ33999789-744EB605-ABA9-4141-97D5-D4C80D560E41Q34071347-AB7299B8-CEBA-4656-A5C1-E2BFF6DBE9E2Q34170651-494F5421-DB15-4947-9F5B-84E48BB53EEBQ34439294-6E6EEA89-240E-4850-B33F-52DC28D850E8Q34684352-37F9FBF0-E7C1-4889-8303-374857323BC8Q36301639-4DD55674-7FDE-478E-A0FC-7DF184BEAE13Q36801734-7567ADAF-C582-4E28-9A9B-0814CC6D9D2FQ37408792-5A365DF8-4203-4853-9AC5-CBDD4FDB53D2Q37434514-08EF66E7-CAAD-42CE-8A45-7E74F6FA57E3Q37705428-2BEC0504-F4BA-45D1-BF67-68313081EF0EQ37843988-2AE4D732-BA2E-4082-9636-910CA667A0F5Q38008992-51DCB3B7-3E4E-479F-B65A-44F8B0FF3C07Q39905396-3E7ED33C-B204-44CF-8AA9-7FA3D0EF2ED0Q44950782-36E78A88-D03F-475F-BDD7-986BE4000CD8Q47176588-F5A50AF4-90E2-49C9-8D5A-8AE66250E092
P2860
Towards a molecular characterisation of pathological pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Towards a molecular characterisation of pathological pathways.
@en
Towards a molecular characterisation of pathological pathways.
@nl
type
label
Towards a molecular characterisation of pathological pathways.
@en
Towards a molecular characterisation of pathological pathways.
@nl
prefLabel
Towards a molecular characterisation of pathological pathways.
@en
Towards a molecular characterisation of pathological pathways.
@nl
P2860
P50
P1433
P1476
Towards a molecular characterisation of pathological pathways
@en
P2093
Jordi Naval
José Manuel Mas
P2860
P304
P356
10.1016/J.FEBSLET.2008.02.014
P407
P577
2008-02-20T00:00:00Z